Reuters logo
5 months ago
BRIEF-Fountain Biopharma gets patent in U.S for methods for producing recombinant glycoproteins with modified
February 16, 2017 / 12:11 PM / 5 months ago

BRIEF-Fountain Biopharma gets patent in U.S for methods for producing recombinant glycoproteins with modified

1 Min Read

Feb 16 (Reuters) - Fountain Biopharma Inc:

* Says it got patent in U.S for methods for producing recombinant glycoproteins with modified

Source text in Chinese: goo.gl/5rscSN

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below